Label: ZANTAC 360- famotidine tablet, film coated
-
Contains inactivated NDC Code(s)
NDC Code(s): 52904-926-04 - Packager: Select Corporation
- This is a repackaged label.
- Source NDC Code(s): 41167-0360
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: Abbreviated New Drug Application
Drug Label Information
Updated April 13, 2022
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- SPL UNCLASSIFIED SECTION
- Active ingredient (in each tablet)
- Purpose
- Uses
-
Warnings
Do not use
- if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor.
- with other acid reducers
Ask a doctor before use if you have
- had heartburn over 3 months. This may be a sign of a more serious condition.
- heartburn with lightheadedness, sweating, or dizziness
- chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
- frequent chest pain
- frequent wheezing, particularly with heartburn
- unexplained weight loss
- nausea or vomiting
- stomach pain
- kidney disease
Ask a doctor or pharmacist before use if you are taking a prescription drug. Acid reducers may interact with certain prescription drugs.
-
Directions
- adults and children 12 years and over:
- to relieve symptoms, swallow 1 tablet with a glass of water. Do not chew.
- to prevent symptoms, swallow 1 tablet with a glass of water at any time from 10 to 60 minutes before eating food or drinking beverages that cause heartburn
- do not use more than 2 tablets in 24 hours
- children under 12 years: ask a doctor
- adults and children 12 years and over:
- Other information
- Inactive ingredients
- Questions or Comments?
- SPL UNCLASSIFIED SECTION
- PRINCIPAL DISPLAY PANEL - 1 Tablet Pouch Blister Pack
-
INGREDIENTS AND APPEARANCE
ZANTAC 360
famotidine tablet, film coatedProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:52904-926(NDC:41167-0360) Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength famotidine (UNII: 5QZO15J2Z8) (famotidine - UNII:5QZO15J2Z8) famotidine 10 mg Inactive Ingredients Ingredient Name Strength carnauba wax (UNII: R12CBM0EIZ) STARCH, CORN (UNII: O8232NY3SJ) magnesium stearate (UNII: 70097M6I30) microcrystalline cellulose (UNII: OP1R32D61U) ferric oxide red (UNII: 1K09F3G675) talc (UNII: 7SEV7J4R1U) titanium dioxide (UNII: 15FIX9V2JP) hydroxypropyl cellulose (1600000 WAMW) (UNII: RFW2ET671P) SODIUM STARCH GLYCOLATE TYPE A CORN (UNII: AG9B65PV6B) hypromellose 2910 (5 mpa.s) (UNII: R75537T0T4) Product Characteristics Color PINK Score no score Shape ROUND (biconvex) Size 5mm Flavor Imprint Code CC;58 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:52904-926-04 1 in 1 BLISTER PACK 04/12/2021 1 1 in 1 POUCH; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date ANDA ANDA206531 04/12/2021 Labeler - Select Corporation (053805599)